| 发明名称 |
PYRIMIDINE COMPOUND |
| 摘要 |
Disclosed is a novel and excellent method for preventing and/or treating cannabinoid-2 receptor-related diseases, which is based on an agonist action on cannabinoid-2 receptors. Specifically disclosed is a heterocyclic derivative mainly having two substituents, for example, a pyrimidine-5-carboxylic acid amide derivative having a substituted amino group at the 2-position, which has a strong agonist action on cannabinoid-2 receptors. The derivative can be an agent for preventing and/or treating diseases related to cannabinoid-2 receptors, such as inflammatory diseases and pains.
|
| 申请公布号 |
CA2757188(A1) |
申请公布日期 |
2010.10.07 |
| 申请号 |
CA20102757188 |
申请日期 |
2010.03.29 |
| 申请人 |
ASTELLAS PHARMA INC. |
发明人 |
MATSUSHIMA, YUJI;KUBOTA, HIROKAZU;HAMAGUCHI, HISAO;OKAMOTO, YOSHINORI;HONDO, TAKESHI;NISHIGAKI, FUSAKO |
| 分类号 |
C07D239/34;A61K31/505;A61K31/506;A61K31/5377;A61K31/538;A61K31/541;A61K31/55;A61P1/02;A61P1/04;A61P1/08;A61P1/10;A61P1/12;A61P1/14;A61P1/16;A61P1/18;A61P3/04;A61P3/10;A61P5/14;A61P7/00;A61P7/02;A61P7/06;A61P9/00;A61P9/02;A61P9/04;A61P9/06;A61P9/08;A61P9/10;A61P9/12;A61P11/00;A61P11/02;A61P11/06;A61P11/14;A61P13/10;A61P13/12;A61P15/00;A61P15/08;A61P17/00;A61P17/02;A61P17/04;A61P17/06;A61P17/16;A61P19/02;A61P19/04;A61P19/06;A61P19/08;A61P19/10;A61P21/00;A61P21/02;A61P21/04;A61P25/00;A61P25/02;A61P25/04;A61P25/06;A61P25/08;A61P25/14;A61P25/16;A61P25/18;A61P25/20;A61P25/22;A61P25/24;A61P25/28;A61P25/30;A61P27/02;A61P27/06;A61P27/12;A61P29/00;A61P29/02;A61P31/04;A61P31/06;A61P31/12;A61P31/18;A61P33/00;A61P35/00;A61P35/02;A61P37/02;A61P37/06;A61P37/08;A61P43/00;C07D239/38;C07D239/42;C07D239/48;C07D401/04;C07D401/06;C07D401/12;C07D403/04;C07D403/12;C07D405/12;C07D405/14;C07D409/12;C07D413/06;C07D451/04;C07D453/02;C07D491/107;C07D493/08 |
主分类号 |
C07D239/34 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
